Free Trial

This company has been marked as potentially delisted and may not be actively trading.

BioTelemetry (BEAT) Short Interest Ratio & Short Volume

BioTelemetry logo

BioTelemetry Short Interest Data

BioTelemetry (BEAT) has a short interest of 112,300 shares, representing 0.45% of the float (the number of shares available for trading by the public). This marks a 3.89% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.6, indicating that it would take 1.6 days of the average trading volume of 102,953 shares to cover all short positions.

Current Short Interest
112,300 shares
Previous Short Interest
108,100 shares
Change Vs. Previous Month
+3.89%
Dollar Volume Sold Short
$188.44 thousand
Short Interest Ratio
1.6 Days to Cover
Last Record Date
May 31, 2025
Outstanding Shares
26,670,000 shares
Float Size
24,820,000 shares
Short Percent of Float
0.45%
Today's Trading Volume
118,715 shares
Average Trading Volume
102,953 shares
Today's Volume Vs. Average
115%
Short Selling BioTelemetry?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for BioTelemetry and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

BEAT Short Interest Over Time

BEAT Days to Cover Over Time

BEAT Percentage of Float Shorted Over Time

BioTelemetry Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/31/2025112,300 shares $188.44 thousand +3.9%0.5%1.6 $1.68
5/15/2025108,100 shares $169.18 thousand -25.6%0.4%1.7 $1.57
4/30/2025145,200 shares $254.68 thousand +24.1%0.6%2 $1.75
4/15/2025117,000 shares $193.64 thousand -23.2%0.5%1.3 $1.66
3/31/2025152,400 shares $305.56 thousand -31.4%0.6%1.7 $2.01
3/15/2025222,100 shares $454.19 thousand -3.2%0.9%2.1 $2.05
2/28/2025229,400 shares $456.51 thousand +5.0%0.9%1.4 $1.99
2/15/2025218,500 shares $469.56 thousand -23.5%1.1%1.3 $2.15
1/31/2025285,600 shares $682.58 thousand -2.3%1.5%1.7 $2.39
1/15/2025292,200 shares $610.70 thousand -15.4%1.5%1.8 $2.09
12/31/2024345,400 shares $746.06 thousand +100.5%1.8%2.2 $2.16
12/15/2024172,300 shares $537.58 thousand +26.7%0.9%1.1 $3.12
11/30/2024136,000 shares $416.16 thousand +78.7%0.7%1.4 $3.06
11/15/202476,100 shares $174.27 thousand -51.2%0.4%0.9 $2.29
10/31/2024155,900 shares $377.28 thousand +24.5%0.8%2.2 $2.42
10/15/2024125,200 shares $287.96 thousand -7.2%0.6%1.9 $2.30
9/30/2024134,900 shares $312.97 thousand +64.3%0.7%2.2 $2.32
9/15/202482,100 shares $181.44 thousand -30.5%0.4%1.2 $2.21
8/31/2024118,200 shares $277.77 thousand -34.2%0.6%1.5 $2.35
8/15/2024179,700 shares $415.11 thousand -9.0%0.9%1.7 $2.31
7/31/2024197,400 shares $515.21 thousand -42.4%1.0%1.7 $2.61
7/15/2024342,600 shares $993.54 thousand +33.6%1.8%3.1 $2.90
6/30/2024256,500 shares $659.21 thousand -4.8%1.3%2.2 $2.57
6/15/2024269,500 shares $619.85 thousand +90.5%1.4%2.7 $2.30
5/31/2024141,500 shares $393.37 thousand +165.5%0.7%1.2 $2.78
5/15/202453,300 shares $114.60 thousand -55.1%0.3%0.4 $2.15
4/30/2024118,600 shares $238.39 thousand -14.5%0.6%1 $2.01
4/15/2024138,700 shares $255.21 thousand -13.0%0.7%1.1 $1.84
3/31/2024159,400 shares $347.49 thousand +20.7%0.8%1.2 $2.18
3/15/2024132,100 shares $318.36 thousand +247.6%0.7%0.4 $2.41
2/29/202438,000 shares $55.10 thousand -13.8%0.2%0.1 $1.45
2/15/202444,100 shares $79.38 thousand +13.4%0.2%0.2 $1.80
1/31/202438,900 shares $72.74 thousand -37.3%0.2%0.2 $1.87
1/15/202462,000 shares $104.16 thousand -62.3%0.3%0.3 $1.68
12/31/2023164,500 shares $386.58 thousand +383.8%0.8%0.7 $2.35
12/15/202334,000 shares $42.50 thousand +21.9%0.2%0.2 $1.25
11/30/202327,900 shares $40.46 thousand -44.6%0.1%0.5 $1.45
11/15/202350,400 shares $61.49 thousand +3.9%0.3%0.9 $1.22
10/31/202348,500 shares $60.14 thousand -12.8%0.3%0.9 $1.24
10/15/202355,600 shares $81.73 thousand -25.0%0.3%1.1 $1.47
Billionaires are piling into this gold investment (Ad)

Billionaires Are Piling into a Special Gold Investment With record gold prices, everyday Americans are scrambling to buy gold coins and bars. But some savvy investors have used a different way to profit from gold bull runs — a special investment with a long history of making 13 times … 21 times … 157 times … even a surprising 1,000 times more than physical gold.

Click here to see how to make the most out of this historic gold bull market.
9/30/202374,100 shares $159.32 thousand -3.9%0.4%1.2 $2.15
9/15/202377,100 shares $189.67 thousand +15.9%0.4%0.9 $2.46
8/31/202366,500 shares $138.99 thousand -14.9%0.4%0.6 $2.09
8/15/202378,100 shares $194.47 thousand -40.1%0.4%0.2 $2.49
7/31/2023130,400 shares $396.42 thousand -18.9%2.2%0.3 $3.04
7/15/2023160,700 shares $515.85 thousand +31.5%2.7%0.3 $3.21
6/30/2023122,200 shares $294.50 thousand -4.8%2.0%0.2 $2.41
6/15/2023128,300 shares $346.41 thousand -29.6%2.1%0.3 $2.70
5/31/2023182,200 shares $428.17 thousand +103.8%16.7%0.4 $2.35
5/15/202389,400 shares $194.00 thousand No Change3.8%1.3 $2.17
10/31/2022347,000 shares $1.16 million -5.0%9.3%0.1 $3.33
10/15/2022365,400 shares $1.41 million -29.5%9.7%0.1 $3.87
9/30/2022518,000 shares $2.02 million +1,367.4%13.8%0.1 $3.90
9/15/202235,300 shares $81.90 thousand -46.1%0.9%0 $2.32
8/31/202265,500 shares $83.84 thousand +26.2%1.8%0.7 $1.28
8/15/202251,900 shares $80.45 thousand -38.5%1.4%0.6 $1.55
7/31/202284,400 shares $119.00 thousand +8.3%2.3%1.2 $1.41
7/15/202277,900 shares $105.94 thousand -7.2%2.1%1.1 $1.36
6/30/202283,900 shares $108.23 thousand -17.8%2.1%0.5 $1.29
6/15/2022102,000 shares $132.60 thousand -5.9%2.6%0.7 $1.30
5/31/2022108,400 shares $157.18 thousand +43.6%2.7%0.7 $1.45
5/15/202275,500 shares $101.93 thousand -34.9%1.9%0.5 $1.35
4/30/2022115,900 shares $158.78 thousand +26.7%3.0%0.7 $1.37
4/15/202291,500 shares $147.32 thousand -13.2%2.4%0.5 $1.61
3/31/2022105,400 shares $194.36 thousand +100.4%N/A1 $1.84
3/15/202252,600 shares $87.84 thousand +9.1%1.4%0.2 $1.67
2/28/202248,200 shares $84.35 thousand -32.8%1.3%0.2 $1.75
2/15/202271,700 shares $126.19 thousand -50.3%1.9%0.3 $1.76
1/31/2022144,200 shares $312.91 thousand +29.4%3.8%0.4 $2.17
1/15/2022111,400 shares $357.59 thousand +62.4%N/A0.3 $3.21
12/31/202168,600 shares $211.29 thousand No Change1.8%0.2 $3.08
1/29/20211,100,000 shares $79.24 million -49.1%3.3%1.3 $72.04
1/15/20212,160,000 shares $155.82 million +3.4%6.5%3.1 $72.14
12/31/20202,090,000 shares $150.48 million -31.3%6.3%3.3 $72.00
12/15/20203,040,000 shares $183.77 million -13.6%9.2%5.8 $60.45
11/30/20203,520,000 shares $189.87 million -0.9%10.6%10.6 $53.94
11/15/20203,550,000 shares $168.63 million -7.8%10.7%10.9 $47.50
10/30/20203,850,000 shares $160.58 million +8.8%11.6%12.1 $41.71
10/15/20203,540,000 shares $157.74 million -9.2%10.7%10.2 $44.56
9/30/20203,900,000 shares $177.76 million -1.8%11.8%11 $45.58
9/15/20203,970,000 shares $161.62 million -0.3%12.0%10.5 $40.71
8/31/20203,980,000 shares $157.53 million +5.6%12.0%11.5 $39.58
8/14/20203,770,000 shares $162.45 million +18.9%11.4%11.3 $43.09
7/31/20203,170,000 shares $134.92 million +6.4%9.6%9.3 $42.56
7/15/20202,980,000 shares $123.19 million +13.7%9.0%9.2 $41.34
6/30/20202,620,000 shares $118.40 million +24.8%7.9%8 $45.19

BEAT Short Interest - Frequently Asked Questions

What is BioTelemetry's current short interest?

Short interest is the volume of BioTelemetry shares that have been sold short but have not yet been covered or closed out. As of May 31st, traders have sold 112,300 shares of BEAT short. 0.45% of BioTelemetry's shares are currently sold short. Learn More on BioTelemetry's current short interest.

What is a good short interest ratio for BioTelemetry?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BEAT shares currently have a short interest ratio of 2.0. Learn More on BioTelemetry's short interest ratio.

What is a good short interest percentage for BioTelemetry?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.45% of BioTelemetry's floating shares are currently sold short.

Is BioTelemetry's short interest increasing or decreasing?

BioTelemetry saw a increase in short interest in May. As of May 31st, there was short interest totaling 112,300 shares, an increase of 3.9% from the previous total of 108,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is BioTelemetry's float size?

BioTelemetry currently has issued a total of 26,670,000 shares. Some of BioTelemetry's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. BioTelemetry currently has a public float of 24,820,000 shares.

How does BioTelemetry's short interest compare to its competitors?

0.45% of BioTelemetry's shares are currently sold short. Here is how the short interest of companies in the industry of "surgical & medical instruments" compare to BioTelemetry: Alpha Tau Medical Ltd. (0.19%), BrainsWay Ltd. (0.68%), Sight Sciences, Inc. (4.26%), TriSalus Life Sciences, Inc. (0.21%), The Beauty Health Company (11.33%), Profound Medical Corp. (1.81%), Utah Medical Products, Inc. (3.07%), CVRx, Inc. (9.61%), Anika Therapeutics, Inc. (3.00%), AVITA Medical, Inc. (16.10%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($64.96 billion), Invesco QQQ ($27.88 billion), iShares Russell 2000 ETF ($19.94 billion), iShares 20+ Year Treasury Bond ETF ($9.69 billion), Strategy Incorporated ($8.58 billion), SPDR S&P Biotech ETF ($5.72 billion), Invesco S&P 500 Equal Weight ETF ($5.45 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.70 billion), Charter Communications, Inc. ($4.54 billion), and Industrial Select Sector SPDR Fund ($4.49 billion). View all of the most shorted stocks.

What does it mean to sell short BioTelemetry stock?

Short selling BEAT is an investing strategy that aims to generate trading profit from BioTelemetry as its price is falling. BEAT shares are trading down $0.59 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against BioTelemetry?

A short squeeze for BioTelemetry occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BEAT, which in turn drives the price of the stock up even further.

How often is BioTelemetry's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BEAT, twice per month. The most recent reporting period available is May, 31 2025.




This page (NASDAQ:BEAT) was last updated on 6/16/2025 by MarketBeat.com Staff
From Our Partners